This page contains a Flash digital edition of a book.
| EDITORIAL F Affiliated partners: Delicious Flickr


IRSTLY, HAPPY NEW YEAR TO ALL OUR READERS, COLLEAGUES AND friends! Last year was a fantastic year for us and hopefully 2013 will be just as prosperous as we celebrate PRIMEÕs second birthday and the launch of PRIME North America. When the anti-ageing and aesthetic effects of botulinum toxin were first approved for use, it was hailed as a Ôwonder drugÕ for facial rejuvenation and the


erasure of those pesky frown lines. As product development and treatment techniques have continually improved over the past decade, the treatment has become one of the most popular and most sought-after by patients wishing to halt the signs of ageing. It is no secret either that botulinum toxin ® and particularly Botox ® can be used for other


medical purposes, such as in the treatment of hyperhidrosis, blepharospasm and chronic migraine, making this product formulation an incredible asset in the medical arsenal. However, it doesnÕ t just stop there, as recent research has shown that Botox may also


show benefits for those patients suffering from clinical depression. In a study published in the Journal of Psychiatric Research last May, researchers studied


Researchers studied the effects of Botox Ô therapyÕ in 30 patients who had been suffering from long-term drug-resistant depression.


the effects of Botox Ô therapyÕ in 30 patients who had been suffering from long-term drug-resistant depression, half of whom received placebo, and the other half receiving five injections of Botox. After 6 weeks it was found that the Botox cohort


saw a 47% decrease in depressive symptoms, while the placebo group only saw a 9% decrease. These results were recently supported by a study


presented at the American College of Neuropsychopharmacology meeting in December 2012. A group of researchers from the Chevy Chase


Cosmetic Center in Maryland, US, examined 84 individuals who had drug-resistant severe depression


lasting for an average of 2 years. This was also a placebo-controlled study, and found that over a quarter of those who had received Botox had a Ônearly complete remission of their depressionÕ , compared with 7% in the placebo cohort. This is clearly exciting news for the medical community, but clearly more in-depth


research is needed before regulatory authorities will even consider adding this treatment indication. It is postulated that Botox could affect depression in a biological way, such as through the


immune system, which is often altered with the condition. Regardless, the results of both studies provide an interesting mindÐ body connection.


Rosalind Hill Managing Editor, PRIME rosalind.hill@informa.com twitter.com/PrimeJournal


Twitter Retweet Facebook MySpace StumbleUpon Digg


You can download the PRIME App for FREE by searching for ÔPrime JournalÕ in the App Store.


FIND US ON TWITTER, FACEBOOK & LINKEDIN Slash Dot


Join PRIMEÕs editorial team for the latest updates in aesthetic and anti-ageing medicine, debates, and interaction with your peers and colleagues, conference information and special offers


Mixx


Follow us @PrimeJournal


s Flickr Reddit TwitterFriendFeed @PrimeJournal Follow us Retweet Delicious Skype


Search for Prime Journal


Facebook YouTube Flickr Technorati


Search for Prime Journal


MySpace LinkedIn prime-journal.com | January/February 2013 ❚


StumbleU 3


Twitter


Industry Insider





E-Marketing





Body Augmentation





Industry News





Regulatory Affairs


Jan/Feb 2013 Volume 3


❙ Issue 1 INTERNATIONAL JOURNAL OF AESTHETIC AND ANTI-AGEING MEDICINE


TEAR TROUGH REJUVENATION


LIPOSCULPTURE TO THE LOWER FACE


CERVICOFACIAL


AUGMENTATION OF THE HANDS


USING DERMAL FILLERS


CHRONIC FATIGUE SYNDROME


MANAGEMENT STRATEGIES


EUROPE


Jan/Feb 2013 ❙ Volume 3


❙ Issue 1


INTERNATIONAL JOURNAL OF AESTHETIC AND ANTI-AGEING MEDICINE


prime-journal.com


with hyaluronic acid


Cover image Shutterstock Retouching Linda Duong


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92